Pleuropulmonary blastoma is a dysontogenetic neoplasm of childhood, histologically characterized by a primitive variably mixed blastematous and sarcomatous appearance. It presents a pattern of rapid growth and is associated with a poor prognosis. We report the case of a 13-month-old girl, consulting for wheezing, dyspnea and loss of appetite. Chest X-ray revealed a mediastinal deviation with a clear appearance of the right lung. Computed tomography showed a voluminous emphysematous bulla of the right lung and atelectasis of the lower lobe. The final diagnosis was made on the basis of histological features of a cystic tumour, showing blastematous elements associated with sarcomatous compound confirming the diagnosis of pleuropulmonary blastoma type I. Subsequent chemotherapy was performed. Four years after the operation, the child is well with no evidence of disease recurrence or metastasis.
Introduction
Pleuropulmonary blastoma (PPB) is an uncommon solid and/or cystic intrathoracic childhood tumour, which belongs to the group of dysontogenetic, neoplasms such as wilms' tumour, hepatoblastoma and neuroblastoma. It also affects adults and appears as pulmonary and/or pleural-based mass, histologically characterized by a primitive variably mixed blastematous and sarcomatous appearance. 1 It presents a pattern of rapid growth and is associated with a poor prognosis. 2 
Case report
A 13-month-old girl was admitted to the paediatric surgical department when she presented with a one-week history of wheezing and dyspnea accompanied by loss of appetite. For 3 days, she had vomiting, diarrhoea and fever. Physical examination revealed a respiratory rate at 38/min with nasal flare, intercostal retraction and asymmetric chest. Pulmonary auscultation revealed decreased breath sound in the right middle and lower chest, without sibilant rale. Cardio-vascular examination was normal. There was neither hepatosplenomegaly nor peripheral lymphadenopathy and no abnormal neurological symptoms. Chest X-ray revealed a mediastinal shift with a clear appearance of the 2/3 of the right lung associated with a liquid level ( Fig. 1 ). Computed tomography showed what was considered as a voluminous emphysematous bulla of the right lung and atelectasis of the lower lobe associated with an abundant pleural effusion ( Fig. 2) . A thoracotomy was then performed to relieve the patient, but it revealed a voluminous tumour, measuring 15 cm in size, localized in the upper lobe of the right lung. The latter was compressed and repressed forward. After extraction of the tumour and resection of the paracardiac lower lobe, examination of the thoracic cavity showed no significant adherence between the upper lobe and the parietal pleura. There was no evidence of extension of this mass to the chest wall or pericardium and no implants on the pleura. There were no obviously enlarged mediastinal nodes. On macroscopic examination, the tumour weighed 480 g and measured 13 Â 10 Â 7 cm. At the cutting section, it was cystic and multiloculated, containing 1 L of clear serous fluid. The walls of cysts were thick, measuring 1-1.5 cm ( Fig. 3 ). On microscopic examination, the cystic walls were lined with a high cylindrical epithelium, often ciliated, standing on a stroma with a hypocellular appearance associated with a cellular cambium layer, composed of round to spindle shaped immature cells. Occasionally, some mesenchymal cells had a rhabdomyoblastic differentiation ( Fig. 4) . A marked vascular network was noted. No sarcomatous features were depicted in different samples. Based on these features, the diagnosis of PPB type I was confirmed. The child was then referred to an oncologist who prescribed 6 courses of chemotherapy (IVA) with Holoxan, Actinomycin and Oncovin. At present, 4 years after treatment, the child is well with no evidence of disease recurrence or metastasis.
Discussion
PPB is a rare primary malignant lung tumour, accounting for 0.25-0.5% of primary lung tumours. 1 It was first described by Barnard in 1952 who named it embryoma of lung and was subsequently redefined by both Spencer in 1961 and Manivel in 1988. Since then, approximately 150 cases have been reported in the literature. 3, 4 While 60% or more of cases occur in adults over 40 years, 20% occur in patients under 20 years and 75% of these are under 10 years. 3 An exceptional case of PPB has been diagnosed prenatally, at 32 weeks of gestation. 5 Most series report a female predominance. 6 Symptoms can be unspecific, such as dry cough, fever, chest or abdominal pain and infections that persist despite medical therapy. The uncommon symptoms are dyspnea and pneumothorax or respiratory distress. Our patient was a 13-monthold girl, presenting with wheezing, dyspnea and loss of appetite. In 20% of the cases, the tumour is discovered fortuitously. 7, 8 In 38%, children with PPB had radiologically identified pulmonary cysts, prior to surgery. In more than one-third of these instances, the cysts were supposed to be developmental or infectious and the children were just watched over for several months often until a suspicious, solid component had been developed. A computed tomography scan examination confirms the cystic lesion and shows possible zones of necrosis, solid component or pleural involvement. 9, 10 Based on radiological features, several other diagnoses were suspected like hydatid or bronchogenic cyst, pulmonary abscess, cystic adenoma and congenital adenomatoid malformation. Imaging study showed in the present case an emphysematous bulla, and the diagnosis of PPB was done by histological examination. This tumour can be divided into 3 morphologic types, based on its cystic, cystic and solid, or solid character, as determined by the gross and microscopic findings The exclusively cystic or type I PPB is the least complex and is presented at an earlier age than either type II or type III PPB. 1 The cystic lesion is usually located in the periphery of the lobe in which it arises or occurs in the right lung, particularly in the right lower lobe. It is believed that these three types are a continuum: type I lesion progresses to type II and type III as the cysts are replaced by a solid malignant tissue. 9, 10 In subsequent recurrences the tumour becomes solid, anaplastic, multiphasic with mesenchymal pattern. The gross features of type III PPB is purely solid consisting of friable, gelatinous to mucoide, lobulated tissue often accompanied by haemorrhage and necrosis. 10 Histologically, childhood PPB, unlike the adulthood one has embryoniclike blastema and stroma, with the absence of a carcinomatous component and potential for sarcomatous differentiation. Blastematous foci are consistently seen and contain numerous mitotic features and areas resembling rhabdomyosarcoma with large, bizarre, pleomorphic, multinucleated mesenchymal cells present over half of the cases. Immature and sarcomatous cartilage is present in about 25% of the cases. 3 In our case report, the tumour was a PPB type I, diagnosed during histologic examination. Type I lesions must be histologically differentiated from cystic adenamatoid malformation and bronchogenic cyst. Type III must be differentiated from the pulmonary tumours of childhood, such as inflammatory myofibroblastic tumour, Askin thoraco-abdominal primitive neuroectodermal tumour, pulmonary metastasis and pulmonary lymphoma. 9 The histogenesis of PPB is still undetermined. The co-expression of cytokeratin and vimentin in the blastematous component provides some support to the concept that a pluripotential blastematous cell may give rise to the epithelial and mesenchymal elements of PPB. It has also been suggested that PPB originates from residual embryonic tissue in the lung, which through genetic and/or environmental influences, generates pluripotential cells with different degrees of differentiation. Various hypotheses have been formulated on the association of PPB with pre-existing cystic disease of the lung including congenital adenomatoid malformation, extralobar sequestration and bronchogenic cysts. Priest reported that PPB and congenital lung cysts may be associated in 38% of cases. Yet, the progression of congenital adenomatoid malformation to PPB is to be proved and these two entities are said to be curiously associated. However, PPB has recently been identified in utero, indicating that these lesions may be congenital in origin and thus malignant from the beginning. 7, 11 Cytogenetic studies have repeatedly reported trisomy of chromosome 8 or, more generally, gains of chromosome 8 in addition to complex genetic abnormality. Furthermore, trisomy of chromosome 2 has been reported by fluorescence in situ hybridization (FISH). 11 PPB is known to have a family association with other neoplasms, but only two cases of PPB occurring in siblings were reported in the literature. 12 Autopsy case reports cited in the literature document widespread visceral metastases in the central nervous system, especially the brain, but also the orbit, and the iris. Other common sites of metastases include bones, liver, soft tissues, lymph nodes, pancreas, kidney and adrenals. 8, 13, 14 The prognosis of PPB is generally poor, with 5 year-survival of only 45% and 2 yearsurvival of 62%. 13, 15 The prognosis is better for type I, which has a survival rate of 83%, but only 42% for type II and III and this is even after multimodality therapy. Primary treatment consists of radical surgery. The surgical procedure of choice is lobectomy, as the border between the lesion and normal parenchyma may be difficult to determine grossly, and usually the tumour spreads into lung parenchyma. 7 Some authors suggest that postoperative chemotherapy should be strongly considered with type I to minimise the possibility of recurrence. A combination of vincristine, actinomycin-D and cyclophosphamide has been used. 10 Adjuvant therapy has also been used for type II and III while radiotherapy is recommended for tumours with known areas of residual disease. 7, 10 Adjuvant chemotherapy was given to our patient who is at present, 4 years later, well with no evidence of disease.
Conclusion
Congenital cystic lesions should be followed up and never underestimated because they may conceal a PPB. Diagnosis is usually histologic and treatment should be submitted to a joint analysis from a pulmonologist, an oncologist and a thoracic surgeon. Early definitive surgery in PPB may have a positive impact on survival. After resection, postoperative chemotherapy is strongly recommended to prevent distant spread of the disease or transition from PPB type I to PPB type III.
